Dave Messina

Member of Selection Committee @Iselect Fund

San Diego, CA, US
EMAILS
d•••@pioneerfund.vc
MOBILE NUMBERS
+13•••••••77

Signup · Get unlimited contacts

WORK HISTORY

Sep 2016 — Present

Member of Selection Committee @Iselect Fund

View department →

EDUCATION

1994 — 1996

University of Illinois Chicago

Bachelor of Science (BS), Biology

1998 — 2004

Washington University School of Medicine in St. Louis

Master of Science (MS), Genetics

2007 — 2012

Stockholm University

Doctor of Philosophy (Ph.D.), Computational Biology

SKILLS

BioinformaticsGenomicsSequence AnalysisMicroarray AnalysisMetagenomicsHuman GeneticsComputational BiologyBioperlBiologyGeneticsSequencingMolecular BiologyPerlPopulation GeneticsMicroarrayInformaticsComparative GenomicsRDna SequencingLifesciencesScienceProteomicsMolecular EvolutionTranscriptomicsFunctional GenomicsDnaExperimental DesignMolecular GeneticsGene Expression ProfilingRnaseqLife SciencesCommunity Outreach

ABOUT DAVE MESSINA

Founder and General Partner of Pioneer\'s Future of Health Fund, a fund of 100+ Y Combinator healthtech alumni investing in top Y Combinator health startups.I\'ve spent 25+ years in healthcare and have been leading healthcare investments at Pioneer Fund since 2019.To date, I\'ve led 100+ deals, including- Gilgamesh ($1B exit to Abbvie)- Assort Health ($500M+ valuation)- Stepful (20x+ MOIC)- Freshpaint (8-figure ARR)- PostEra ($1B in deals with Pfizer and Amgen). Before venture, I founded the RNA and machine learning company Cofactor Genomics that achieved national Medicare reimbursement for its technology that improves outcomes for cancer patients. Earlier, I worked on the Human Genome Project, authored 20+ research papers, and earned my computational biology PhD in Stockholm, Sweden.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.